Brief: Sellas Life Sciences Group Announces Publication Of Positive GPS Clinical Data In Ovarian Cancer In Peer Reviewed Journal
07/03/2023 13:42
March 7 (Reuters) - Sellas Life Sciences Group Inc
SLS.O :
* SELLAS ANNOUNCES PUBLICATION OF POSITIVE GPS CLINICAL DATA
IN
OVARIAN CANCER IN PEER REVIEWED JOURNAL
Source text for Eikon: ID:nGNXbnhgJn
Further company coverage: SLS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sellas Life Sciences
See all newsBrief: Sellas Life Sciences Reaches 80Th Event In Phase 3 Regal Trial Of Galinpepimut-S (Gps) In Acute Myeloid Leukemia
SELLAS Life Sciences Q2 net loss widens on higher expenses
Brief: SELLAS Life Sciences Q2 Net Income USD -9.605 Million
Arbitrator Dismisses Company's Claims In Arbitration Against 3D Medicines On July 24, 2026 - SEC Filing
SELLAS Life Sciences Q1 net loss widens on higher expenses